Moreover, the neuroprotective and antioxidant features of Lupeol were reported against STZ+AlCl3 in diabetic-induced AD in a rat model, where the reduced blood glucose level, rising level of CAT, SOD and lower GSH level were observed by the oral administration of Lupeol (10 mg/kg) [60]. The gene discussed is CAT; the disease is Alzheimer disease.